上海交通大学学报(医学版) ›› 2018, Vol. 38 ›› Issue (2): 233-.doi: 10.3969/j.issn.1674-8115.2018.02.022

• 综述 • 上一篇    下一篇

肺癌脉络膜转移局部治疗的研究进展

余 欢 1,李庆云 2   

  1. 上海交通大学 医学院附属瑞金医院 1. 眼科,2. 呼吸与危重症医学科,上海 200025
  • 出版日期:2018-02-28 发布日期:2018-03-09
  • 通讯作者: 李庆云,电子信箱:liqingyun68@hotmail.com。
  • 基金资助:
     上海市重中之重临床重点学科建设项目(2017ZZ02014)

Research progress of the local treatments on choroidal metastasis of lung cancer

YU Huan1 , LI Qing-yun2   

  1. 1. Department of Ophthalmology, 2. Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
  • Online:2018-02-28 Published:2018-03-09
  • Supported by:
    Shanghai Key Discipline for Respiratory Diseases, 2017ZZ02014

摘要: 脉络膜是眼内转移癌常见的发生部位。在中国,引起脉络膜转移的原发性肿瘤以肺癌居首。目前,肺癌脉络膜转移的治疗策略以全身治疗与局部治疗相结合为主。主要的局部治疗方法包括放射治疗、经瞳孔温热疗法、光动力疗法、玻璃体内注射、眼球摘除等。该文就肺癌脉络膜转移局部治疗的研究进展进行综述。

关键词: &ensp, 脉络膜转移癌;肺癌;局部治疗

Abstract:

The choroid is one of the most common ocular sites for metastatic disease. Lung cancer is the first cause of choroidal metastasis among primary cancers in China. The current management of choroidal metastasis of lung cancer is based on the combination of systemic treatments and local treatments. The latter mainly include radiotherapy, transpupillary thermotherapy, photodynamic therapy, intravitreous injection and enucleation. This review covers the research progress in local treatments on choroidal metastasis of lung cancer.

Key words: choroidal metastases, lung cancer, local treatment